Top 10 Stocks To Watch For 2018

William Patalon III

Go into just about any small or midsized town or city in America, spend a little bit of time looking around, and you’ll get an introduction to that community’s “Old Money” crowd.

You know what I’m talking about.

These are the families whose names bedeck the local courthouse or town hall, the area parks and ballfields and the community-cementing programs like the philharmonic or historical society.

This is premium content for Private Briefing subscribers only.

As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio – this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you’ll immediately understand why it works so well.

Top 10 Stocks To Watch For 2018: LightInTheBox Holding Co., Ltd.(LITB)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) reportedQ1 2017 earnings as net revenues increased 8.0% to $72.7 million (above the high end of the Company’s guidance of $72.0 million). Net revenues from product sales were $64.8 million versus$61.9 million and net revenues from service and others were $7.9 million versus $5.4 million in the same quarter of 2016. As a percentage of net revenues, service and others accounted for 10.9% during the first quarter of 2017. Total orders of product sales were 1.6 million for the first quarter of 2017 versus1.7 million in the same quarter of 2016 while the total number of product sales customers was 1.2 million versus 1.4 million.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) as a long/buy trade:

Top 10 Stocks To Watch For 2018: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By Johanna Bennett]

    Times are tough for Ralph Lauren (RL). Profit and sales are fallingat theiconic clothingcompany, and investors who bet on a turnaround havelost their shirts on the stock. Adding to its troubles,CEO StefanLarsson is departingfollowing a creative clash with the companys namesake and founder.

    Pessimism, meanwhile, appears to be on the rise.

    According to a report by the financial analytics company S3 Partners, short interest in Ralph Lauren has risen since the start of the year, hitting historical levels. And while that short position is expected to keep expanding, bearish sentiments could turn on a dime.

    Ihor Dusaniwsky at S3 Partners writes:

    RL short interest levels, already at historical highs today, should continue to grow if the recent trend continues, but having made almost 23% in 2016 and 14% in 2017, short sellers may be quick to cover their positions and lock in profits if RLs stock price turns against them.

    Short interest in Ralph Lauren fell in 2016 as the stock price fella nd shorts covered positions, netting a return of 22.6%. So far this year, however, the short position as increased $226 million, or 38% to $815 million as of this morning, according to the S3 report.

    Its a profitable day for those short sellers. Todays 11% decline Ralph Laurens stock price on an $815 million short position has added $90 million to the short sellers collective bottom line.

    Ralph Lauren is down 11.5% in recent market actions to $77.26 a after earlier falling as low as $76.86 a share. Thats the lowest price for the stock since 2010.

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

Top 10 Stocks To Watch For 2018: Icahn Enterprises L.P.(IEP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Precision Auto Care (OTC: PACI) got a boost, shooting up 86 percent to $1.50 following announcement of acquisition by Icahn Enterprises LP (NASDAQ: IEP).

  • [By WWW.GURUFOCUS.COM]

    For the details of Carl Icahn’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn

    These are the top 5 holdings of Carl IcahnIcahn Enterprises LP (IEP) – 129,999,050 shares, 34.82% of the total portfolio. Shares added by 2.30%American International Group Inc (AIG) – 45,644,982 shares, 13.32% of the total portfolio. CVR Energy Inc (CVI) – 71,198,718 shares, 8.08% of the total portfolio. Federal-Mogul Holdings Corp (FDML) – 138,590,141 shares, 6.39% of the total portfolio. Cheniere Energy Inc (LNG) – 32,680,490 shares, 6.05

  • [By Robert Rapier]

    CVR Partners’ fertilizer plant is located in Coffeyville, Kansas, adjacent to the refinery owned by CVR Refining (NYSE: CVRR). CVR Energy (NYSE: CVI), majority-owned by Carl Icahn via Icahn Enterprises (NYSE: IEP), is the general partner and owns most of the units for both CVR Partners and CVR Refining.

  • [By WWW.GURUFOCUS.COM]

    For the details of Carl Icahn’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn

    These are the top 5 holdings of Carl IcahnIcahn Enterprises LP (IEP) – 140,524,155 shares, 36.12% of the total portfolio. Shares added by 8.10%American International Group Inc (AIG) – 45,644,982 shares, 14.29% of the total portfolio. Cheniere Energy Inc (LNG) – 32,680,490 shares, 7.75% of the total portfolio. CVR Energy Inc (CVI) – 71,198,718 shares, 7.17% of the total portfolio. PayPal Holdings Inc (PYPL) – 31,5

  • [By WWW.GURUFOCUS.COM]

    For the details of Carl Icahn’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn

    These are the top 5 holdings of Carl IcahnIcahn Enterprises LP (IEP) – 129,999,050 shares, 34.82% of the total portfolio. Shares added by 2.30%American International Group Inc (AIG) – 45,644,982 shares, 13.32% of the total portfolio. CVR Energy Inc (CVI) – 71,198,718 shares, 8.08% of the total portfolio. Federal-Mogul Holdings Corp (FDML) – 138,590,141 shares, 6.39% of the total portfolio. Cheniere Energy Inc (LNG) – 32,680,490 shares, 6.05

  • [By WWW.GURUFOCUS.COM]

    For the details of Carl Icahn’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn

    These are the top 5 holdings of Carl IcahnIcahn Enterprises LP (IEP) – 140,524,155 shares, 36.12% of the total portfolio. Shares added by 8.10%American International Group Inc (AIG) – 45,644,982 shares, 14.29% of the total portfolio. Cheniere Energy Inc (LNG) – 32,680,490 shares, 7.75% of the total portfolio. CVR Energy Inc (CVI) – 71,198,718 shares, 7.17% of the total portfolio. PayPal Holdings Inc (PYPL) – 31,5

Top 10 Stocks To Watch For 2018: Apple Hospitality REIT, Inc.(APLE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Monday.

    AptarGroup, Inc. (NYSE: ATR) – $0.3200 dividend, 1.6780 percent yield. AptarGroup reported weaker-than-expected Q3 results on Thursday.
    Fidelity Southern Corporation (NASDAQ: LION) – $0.1200 dividend, 2.6359 percent yield. The company, based in Atlanta, Georgia, provides financial products and services for customers.
    Apple Hospitality REIT Inc (NYSE: APLE) – $0.1000 dividend, 6.5826 percent yield. Apple Hospitality REIT, based in Richmond, Virginia, operates as a subsidiary of Apple REIT Companies.
    Targa Resources Corp (NYSE: TRGP) – $0.9100 dividend, 7.7299 percent yield. The Houston, Texas-based company provides midstream natura

Top 10 Stocks To Watch For 2018: Leucadia National Corporation(LUK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Then there were financial results released by Jefferies, a unit of Leucadia National (LUK). Its results are often seen as a harbinger for the big U.S. banks, and the results “appear mixed,” according to JMP analyst Devin Ryan. He explains:

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

  • [By Dan Caplinger]

    Leucadia National (NYSE:LUK) is a difficult business for many investors to understand. The combination of the Jefferies Group financial services company, the National Beef meat processing and supply company, and plenty of other smaller investments present a challenge for those seeking to know the ins and outs of what affects Leucadia’s results. In general, though, conditions in the financial industry have been more volatile than the rest of the business, and Jefferies, therefore, plays a bigger role in how the overall company does.

  • [By Michael Hooper]

    When compared with similar companies, Berkshire Hathaway carries a premium over Markel (NYSE: MKL  ) , valued at 1.15 times book value and a 20 forward P/E ratio; and Leucadia National (NYSE: LUK  ) , valued at 1.10 times book value and a 7.16 trailing P/E.

  • [By Ben Levisohn]

    We delved into Kraft Heinz’s (KHC) earnings beat, and explained the impact of Leucadia National’s (LUK) investment in National Beef on its earnings.

Top 10 Stocks To Watch For 2018: Frontier Communications Corporation(FTR)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was Frontier Communications Corp. (NASDAQ: FTR) which traded down 7% at $13.88. The stocks 52-week range is $1.03 to $14.70. Volume was over 6.1 million versus the daily average of 37.5 million shares.

  • [By Daniel B. Kline]

    Frontier Communications (NASDAQ:FTR) has seen its plan to become a bigger player in the pay television and internet space hit a major roadblock.

    The company completed its $10.54 billion purchase of Verizon’s (NYSE:VZ) wireline business in California, Texas, and Florida (CTF) in April. That deal gave it approximately 3.3 million voice connections, 2.1 million broadband connections, and 1.2 million FiOS video subscribers. Essentially, that was enough to turn a regional player into a national company.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Frontier Communications Corp. (NASDAQ: FTR) which traded down nearly 16% at $14.35. The stocks 52-week range is $13.13 to $74.70. Volume was about 6.6 million versus the daily average of 2.8 million shares.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Frontier Communications Corp. (NASDAQ: FTR) which traded down about 9.8% at $1.29. The stocks 52-week range is $1.29 to $5.53. Volume was 74.0 million versus the daily average of 48.5 million shares.

  • [By Ben Levisohn]

    Frontier Communications (FTR) tumbled to the bottom of the S&P 500 today after getting cut to Neutral from Buy at BofA Merrill Lynch.

    Agence France-Presse/Getty Images

    Frontier Communicationsdropped 5.1% to $2.62, while the S&P 500 declined 0.3% to 2,368.38.

    24/7 Wall St.’sJon C. Ogg excerpts from Merrill Lynch’s note:

    In our view, the challenge for the stock is that as the top line has compressed at a surprising rate, the payout ratio and therefore risk to the dividend, is rising. With a 15% yield already, we see the stock as caught in a negative feedback loop. The market is pricing in a dividend cut that neednt happen now or even in the next several years, but the mere fact the yield is that high carries the risk that the Board and management could simply respond to the market by trimming the dividend proactively. Even if the dividend were cut 50%, we dont believe there would be substantial downside for the stock as the yield would emerge at a relatively more normal 7.5%. Until FTR can show business stability, however, which we had expected in 4Q but now do not expect until 2H at the earliest, irrespective of the attractive yield, we dont believe the stock will be able to outperform.

    Frontier Communications’ market capitalization fell to $3.1 billion today from $3.2 billion yesterday. It reported a net loss of $376 million on sales of $9 billion in 2016.

Top 10 Stocks To Watch For 2018: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology shares gained around 0.85 percent in trading on Friday. Meanwhile, top gainers in the sector included Virtusa Corporation (NASDAQ: VRTU), and Ceragon Networks Ltd (NASDAQ: CRNT).

Top 10 Stocks To Watch For 2018: Conn's, Inc.(CONN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co now outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Lisa Levin]

    Conn's Inc (NASDAQ: CONN) shares were also up, gaining 32 percent to $11.18 after the company reported better-than-expected earnings for its fourth quarter.

  • [By Lisa Levin]

    Conn’s Inc (NASDAQ: CONN) shares dropped 24 percent to $8.95 as the company reported downbeat quarterly results. Conn’s posted a Q1 loss of $0.31 per share on revenue of $389.1 million.

Top 10 Stocks To Watch For 2018: Vanda Pharmaceuticals Inc.(VNDA)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another biotechnology player that looks poised to trigger a big breakout trade is Vanda Pharmaceuticals (VNDA), which is focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders. This stock has been on fire so far in 2013, with shares up a whopping 258%.

    If you take a look at the chart for Vanda Pharmaceuticals, you’ll notice that this stock has recently broke out above some near-term overhead resistance levels at $12.34 to $12.66 a share with solid upside volume. So far, this breakout has held and now shares of VNDA are quickly moving within range of triggering an even bigger breakout trade.

    Traders should now look for long-biased trades in VNDA if it manages to break out above its 52-week high at $13.30 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action 908,467 shares. If that breakout hits soon, then VNDA will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $17 a share.

    Traders can look to buy VNDA off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $12 a share. One could also buy VNDA off strength once it takes out $13.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Stocks To Watch For 2018: The NeutriSci International (NU)

Advisors’ Opinion:

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

  • [By Matthew Briar]

    Indeed, it’s also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

Leave a Reply

Your email address will not be published. Required fields are marked *